News
The southern Indian state of Kerala has defended its decision to introduce Zumba classes in public schools, after the move ...
San Francisco's new drug policies reduce arrests but create treatment bottlenecks. Residents face longer waits as the system ...
4d
GMA Network on MSNHerbosa cites Dengvaxia lesson as PH mulls approval of Qdenga vaccineDepartment of Health Secretary Teodoro Herbosa said the government was evaluating whether to introduce the Qdenga vaccine in ...
Arizona faces a potential government shutdown if a budget isn't passed by June 30. Critical services, including prisons and ...
WEHT Evansville on MSN8d
Students take part in substance abuse prevention programStudents take part in substance abuse prevention program ...
The unfortunate truth is that Big Pharma has put Americans in this position by ripping off U.S. patients when it comes to prescription drug pricing – charging them three times more on average than ...
1. Part D pharmacies work the same way whether you have a Medicare Advantage plan or a stand-alone Part D drug plan. The only significant differences may be the premiums and the plan’s deductible.
UroGen Pharma's FDA nod for UGN-102 fuels recovery, but cash burn raises financing risks. Check out why I am maintaining my Buy rating on URGN stock.
Novo Nordisk is planning Phase 3 clinical trials for a obesity drug combination called amycretin, adding another emerging weight-loss medicine to the list of prospects it has in advanced testing.
WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) says it plans to use artificial intelligence (AI) to help speed the approval of new drugs and medical devices.
WEDNESDAY, June 11, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) says it plans to use artificial intelligence (AI) to help speed the approval of new drugs and medical devices.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results